Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
This page shows a summary and AI analysis only. For the full original article, use the “Read Original” button above.
Finance
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
🤖 AI
AI Summary & AI Analysis
⟳ AI is analyzing this article…